Cecilia Martini

Learn More
In order to deliver low-cost viral capsomeres from a large amount of soluble viral VP6 protein from human rotavirus, we developed and optimized a biotechnological platform in Escherichia coli. Specifically, three different expression protocols were compared, differing in their genetic constructs, ie, a simple native histidine-tagged VP6 sequence, VP6 fused(More)
Invasive candidiasis (IC) represents the leading fungal infection of humans causing life-threatening disease in immunosuppressed and neutropenic individuals including also the intensive care unit patients. Despite progress in recent years in drugs development for the treatment of IC, morbidity and mortality rates still remain very high. Historically,(More)
The postharvest phase has been considered an environment for successful application of biological control agents (BCAs). However, the interactions between fungal pathogen, host (fruit), and antagonist are influenced by several parameters such as temperature, oxidative stresses, oxygen composition and water activity that could determine the success of(More)
  • 1